29300-313-22 : NDC 2026 Code

29300-313-22 : Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride ( Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride )

Additionally :

You can get information about “29300-313-22” NDC code in 29300-313-22 in HTML format

HTML | 29300-313-22 in TXT (Plain Text) format

TXT | 29300-313-22 in PDF (Portable Document Format)

PDF | 29300-313-22 in XML format

XML formats.

NDC Code : 29300-313-22 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "29300-313-22",
    "PackageDescription": "2 BLISTER PACK in 1 CARTON (29300-313-22)  / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (29300-313-61) ",
    "NDC11Code": "29300-0313-22",
    "ProductNDC": "29300-313",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride",
    "DosageFormName": "TABLET, FILM COATED, EXTENDED RELEASE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20240910",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA210507",
    "LabelerName": "Unichem Pharmaceuticals (USA), Inc.",
    "SubstanceName": "CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE",
    "StrengthNumber": "5; 120",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2026-01-01",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20251231",
    "StartMarketingDatePackage": "20250101",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}